Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model

By Ayalasomayajula S.P.   Kompella U.B.  

European Journal of Pharmacology, Vol. 458, Iss. 3, 2003-01 ,pp. : 283-289

Elsevier

Access to resources Recommend Favorite

Clinical Pharmacokinetics and Pharmacodynamics of Celecoxib: A Selective Cyclo-Oxygenase-2 Inhibitor

By Davies N.M.  

Clinical Pharmacokinetics, Vol. 38, Iss. 3, 2000-03 ,pp. : 225-242

Adis International

Access to resources Recommend Favorite

Role of prostaglandins generated by cyclooxygenase-1 and cyclooxygenase-2 in healing of ischemia-reperfusion-induced gastric lesions

By Brzozowski T.   Konturek P.C.   Konturek S.J.   Sliwowski Z.   Drozdowicz D.   Stachura J.   Pajdo R.   Hahn E.G.  

European Journal of Pharmacology, Vol. 385, Iss. 1, 1999-11 ,pp. : 47-61

Elsevier

Access to resources Recommend Favorite

Celecoxib, a selective cyclo-oxygenase-2 inhibitor reduces the severity of experimental colitis induced by dinitrobenzene sulfonic acid in rats

By Cuzzocrea S.   Mazzon E.   Serraino I.   Dugo L.   Centorrino T.   Ciccolo A.   Sautebin L.   Caputi A.P.  

European Journal of Pharmacology, Vol. 431, Iss. 1, 2001-11 ,pp. : 91-102

Elsevier

Access to resources Recommend Favorite

Effect of the Cyclooxygenase-2 Inhibitor Celecoxib on Bronchial Responsiveness and Cough Reflex Sensitivity in Asthmatics

By Dicpinigaitis P.V.  

Pulmonary Pharmacology & Therapeutics, Vol. 14, Iss. 2, 2001-03 ,pp. : 93-97

Academic Press

Access to resources Recommend Favorite